Ambulatory blood pressure monitoring-derived short-term blood pressure variability in primary hyperparathyroidism

Abstract

Introduction

Primary hyperparathyroidism is associated with a cluster of cardiovascular manifestations, including hypertension, leading to increased cardiovascular risk.

Purpose

The aim of our study was to investigate the ambulatory blood pressure monitoring-derived short-term blood pressure variability in patients with primary hyperparathyroidism, in comparison with patients with essential hypertension and normotensive controls.

Methods

Twenty-five patients with primary hyperparathyroidism (7 normotensive,18 hypertensive) underwent ambulatory blood pressure monitoring at diagnosis, and fifteen out of them were re-evaluated after parathyroidectomy. Short-term-blood pressure variability was derived from ambulatory blood pressure monitoring and calculated as the following: 1) Standard Deviation of 24-h, day-time and night-time-BP; 2) the average of day-time and night-time-Standard Deviation, weighted for the duration of the day and night periods (24-h “weighted” Standard Deviation of BP); 3) average real variability, i.e., the average of the absolute differences between all consecutive BP measurements.

Results

Baseline data of normotensive and essential hypertension patients were matched for age, sex, BMI and 24-h ambulatory blood pressure monitoring values with normotensive and hypertensive-primary hyperparathyroidism patients, respectively. Normotensive-primary hyperparathyroidism patients showed a 24-h weighted Standard Deviation (P < 0.01) and average real variability (P < 0.05) of systolic blood pressure higher than that of 12 normotensive controls. 24-h average real variability of systolic BP, as well as serum calcium and parathyroid hormone levels, were reduced in operated patients (P < 0.001). A positive correlation of serum calcium and parathyroid hormone with 24-h-average real variability of systolic BP was observed in the entire primary hyperparathyroidism patients group (P = 0.04, P  = 0.02; respectively).

Conclusion

Systolic blood pressure variability is increased in normotensive patients with primary hyperparathyroidism and is reduced by parathyroidectomy, and may potentially represent an additional cardiovascular risk factor in this disease.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    C. Marcocci, F. Cetani, Clinical practice. Primary hyperparathyroidism. N. Engl. J. Med. 365, 2389–2397 (2011)

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    P. Andersson, E. Rydberg, R. Willenheimer, Primary hyperparathyroidism and heart disease-a review. Eur. Heart J. 25, 1776–1787 (2004)

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    P. Luigi, F.M. Chiara, Z. Laura, M. Cristiano, C. Giuseppina, C. Luciano, P. Giuseppe, C. Sabrina, S. Susanna, C. Antonio, C. Giuseppe, T. Giorgio de, L. Claudio, Arterial hypertension, metabolic syndrome and subclinical cardiovascular organ damage in patients with asymptomatic primary hyperparathyroidism before and after parathyroidectomy: preliminary results. Int. J. Endocrinol. 2012, 408295 (2012)

    Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    M. Curione, S. Amato, S. Di Bona, L. Petramala, D. Cotesta, C. Letizia, Parathyroidectomy erase increased myocardial electrical vulnerability in patients with primary hyperparathyroidism. Int. J. Cardiol. 141(2), 201–202 (2010)

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    E. Osto, F. Fallo, M.R. Pelizzo, A. Maddalozzo, N. Sorgato, F. Corbetti, R. Montisci, G. Famoso, R. Bellu, T.F. Lüscher, S. Iliceto, F. Tona, Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy. Circulation 126, 1031–1039 (2012)

    Article  PubMed  Google Scholar 

  6. 6.

    C. Letizia, P. Ferrari, D. Cotesta, C. Caliumi, R. Cianci, S. Cerci, L. Petramala, M. Celi, S. Minisola, E. D’Erasmo, G.F. Mazzuoli, Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism. J. Hum. Hypertens. 19, 901–906 (2005)

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    T. Ohkubo, A. Hozawa, J. Yamaguchi, M. Kikuya, K. Ohmori, M. Michimata, M. Matsubara, J. Hashimoto, H. Hoshi, T. Araki, I. Tsuji, H. Satoh, S. Hisamichi, Y. Imai, Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J. Hypertens. 20, 2183–2196 (2002)

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    G. Mancia, Short- and long-term blood pressure variability. Present and future. Hypertension 60, 512–517 (2012)

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    M. Kikuya, A. Hozawa, T. Ohokubo, I. Tsuji, M. Michimata, M. Matsubara, M. Ota, K. Nagai, T. Araki, H. Satoh, S. Ito, S. Hisamichi, Y. Imai, Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 36, 901–906 (2000)

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    L. Mena, S. Pintos, N.V. Queipo, J.A. Aizpúrua, G. Maestre, T. Sulbarán, A reliable index for the prognostic significance of blood pressure variability. J. Hypertens. 23, 505–511 (2005)

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    G. Bilo, A. Giglio, K. Styczkiewicz, G. Caldara, A. Maronati, K. Kawecka-Jaszcz, G. Mancia, G. Parati, A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J. Hypertens. 25, 2058–2066 (2007)

    CAS  Article  PubMed  Google Scholar 

  12. 12.

    G. Parati, J.E. Ochoa, P. Salvi, C. Lombardi, G. Bilo, Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes. Diabetes Care 36, S312–S324 (2013)

    Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    G. Mancia, R. Fagard, K. Narkiewicz, J. Redón, A. Zanchetti, M. Böhm, T. Christiaens, R. Cifkova, G. De Backer, A. Dominiczak, M. Galderisi, D.E. Grobbee, T. Jaarsma, P. Kirchhof, S.E. Kjeldsen, S. Laurent, A.J. Manolis, P.M. Nilsson, L.M. Ruilope, R.E. Schmieder, P.A. Sirnes, P. Sleight, M. Viigimaa, B. Waeber, F. Zannad; Task Force Members, ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 31, 1281–1357 (2013)

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    D.W. Cockroft, M.H. Gault, Prediction of creatinine clearance from serum creatinine. Nephron 16, 31–34 (1976)

    Article  Google Scholar 

  15. 15.

    R. Eastell, M.L. Brand i, A.G. Costa, P. D’Amour, D.M. Shoback, R.V. Thakker, Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99, 3570–3579 (2014)

    CAS  Article  PubMed  Google Scholar 

  16. 16.

    J.P. Bilezikian, M.L. Brandi, R. Eastell, S.J. Silverberg, R. Udelsman, C. Marcocci, J.T. Potts, Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the fourth international workshop. J. Clin. Endocrinol. Metab. 99, 3561–3569 (2014)

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  17. 17.

    C.A. Feldstein, M. Akopian, D. Pietrobelli, A. Olivieri, D. Garrido, Long-term effects of parathyroidectomy on hypertension prevalence and circadian blood pressure profile in primary hyperparathyroidism. Clin. Exp. Hypertens. 32(3), 154–158 (2010)

    CAS  Article  PubMed  Google Scholar 

  18. 18.

    P.J. Buizert, N.M. van Schoor, S. Simsek, P. Lips, A.C. Heijboer, M. den Heijer, D.J. Deeg, E.M. Eekhoff, PTH: a new target in arteriosclerosis? J. Clin. Endocrinol. Metab. 98, E1583–E1590 (2013)

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    V. Heyliger, C. Tangpricha, Weber, J. Sharma, Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism. Surgery 146(6), 1042–1047 (2009)

    Article  PubMed  PubMed Central  Google Scholar 

  20. 20.

    C. Gennari, R. Nami, S. Gonnelli, Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems. Miner. Electrolyte. Metab. 21(1–3), 77–81 (1995)

    CAS  PubMed  Google Scholar 

  21. 21.

    N.D. Vlachakis, R. Frederics, M. Velasquez, Sympathetic system function and vascular reactivity in hypercalcemic patients. Hypertension 4(3), 452–458 (1982)

    CAS  Article  PubMed  Google Scholar 

  22. 22.

    M. Kosch, M. Hausberg, K. Vormbrock, K. Kisters, G. Gabriels, K.H. Rahn, M. Barenbrock, Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc. Res. 47(4), 813–818 (2000)

    CAS  Article  PubMed  Google Scholar 

  23. 23.

    I.L. Nilsson, J. Åberg, J. Rastad, L. Lind, Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 126(6), 1049–1055 (1999)

    CAS  Article  PubMed  Google Scholar 

  24. 24.

    T. Neunteufl, S. Heher, G. Prager, R. Katzenschlager, C. Abela, B. Niederle, T. Stefenelli, Effects of successful parathyroidectomy on altered arterial reactivity in patients with hypercalcaemia: results of a 3-year follow-up study. Clin. Endocrinol. 53(2), 229–233 (2000)

    CAS  Article  Google Scholar 

  25. 25.

    J.A. Rodriguez-Portales, C. Fardella, Primary hyperparathyroidism and hypertension: persistently abnormal pressor sensitivity in normotensive patients after surgical cure. J. Endocrinol. Invest. 17(5), 307–311 (1994)

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    N. Garcia de la Torre, J.A.H. Wass, H.E. Turner, Parathyroid adenomas and cardiovascular risk. Endocr. Relat. Cancer. 10(2), 309–322 (2003)

    CAS  Article  PubMed  Google Scholar 

  27. 27.

    S.D. Pierdomenico, M. Di Nicola, A.L. Esposito, R. Di Mascio, E. Ballone, D. Lapenna, F. Cuccurullo, Prognostic value of different indices of blood pressure variability in hypertensive patients. Am. J. Hypertens. 22, 842–847 (2009)

    Article  PubMed  Google Scholar 

  28. 28.

    S.C. Malpas, Neural influences on cardiovascular variability:possibilities and pitfalls. Am. J. Physiol. Heart Circ. Physiol. 282, H6–H20 (2002)

    CAS  Article  PubMed  Google Scholar 

  29. 29.

    T.N. Thrasher, Baroreceptors and the long-term control of blood pressure. Exp. Physiol. 89, 331–335 (2004)

    Article  PubMed  Google Scholar 

  30. 30.

    S.G. Massry, M. Smogorzewski, The effects of serum calcium and parathyroid hormone and the interaction between them on blood pressure in normal subjects and in patients with chronic kidney failure. J. Ren. Nutr. 15, 173–177 (2005)

    Article  PubMed  Google Scholar 

  31. 31.

    G.A. Nickols, Increased cyclic amp in cultured vascular smooth muscle cells and relaxation of aortic strips by parathyroid hormone. Eur. J. Pharmacol. 116, 137–144 (1985)

    CAS  Article  PubMed  Google Scholar 

  32. 32.

    G. Rashid, J. Bernheim, J. Green, S. Benchetrit, Parathyroid hormone stimulates the endothelial nitric oxide synthase through protein kinase A and C pathways. Nephrol. Dial. Transplant. 22, 2831–2837 (2007)

    CAS  Article  PubMed  Google Scholar 

  33. 33.

    A. Virdis, F. Cetani, C. Giannarelli, C. Banti, L. Ghiadoni, E. Ambrogini, D. Carrara, A. Pinchera, S. Taddei, G. Bernini, C. Marcocci, The sulfaphenazole-sensitive pathway acts as a compensatory mechanism for impaired nitric oxide availability in patients with primary hyperparathyroidism: effect of surgical treatment. J. Clin. Endocrinol. Metab. 95, 920–927 (2010)

    CAS  Article  PubMed  Google Scholar 

  34. 34.

    M.R. Rubin, M.S. Maurer, D.J. McMahon, J.P. Bilezikian, S.J. Silverberg, Arterial stiffness in mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 90, 3326–3330 (2005)

    CAS  Article  PubMed  Google Scholar 

  35. 35.

    J.L. Anderson, R.C. Vanwoerkom, B.D. Horne, T.L. Bair, H.T. May, D.L. Lappe, J.B. Muhlestein, Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am. Heart J. 162, 331–339.e2 (2011)

    Article  PubMed  Google Scholar 

  36. 36.

    E. Hagstrom, E. Ingelsson, J. Sundstrom, P. Hellman, T.E. Larsson, L. Berglund, H. Melhus, C. Held, K. Michaelsson, L. Lind, J. Arnlov, Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur. J. Heart. Fail. 12, 1186–1192 (2010)

    Article  PubMed  Google Scholar 

  37. 37.

    N. Levi-Marpillat, I. Macquin-Mavier, A.I. Tropeano, G. Parati, P. Maison, Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension. Hypertens. Res. 37, 585–590 (2014)

    CAS  Article  PubMed  Google Scholar 

  38. 38.

    G. Schillaci, G. Pucci, M. Pirro, M. Monacelli, A.M. Scarponi, M.R. Manfredelli, F. Rondelli, N. Avenia, E. Mannarino, Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism. Atherosclerosis 218, 96–101 (2011)

    CAS  Article  PubMed  Google Scholar 

  39. 39.

    J. Bollerslev, C. Marcocci, M. Sosa, J. Nordenström, R. Bouillon, L. Mosekilde, Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur. J. Endocrinol. 165, 851–864 (2011)

    CAS  Article  PubMed  Google Scholar 

  40. 40.

    A. Persson, J. Bollerslev, T. Rosen, C.L. Mollerup, C. Franco, G.A. Isaksen, T. Ueland, S. Jansson, K. Caidahl; SIPH Study Group, Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism. Clin. Endocrinol. 74, 174–10 (2011)

    Article  Google Scholar 

Download references

Acknowledgements

This research did not receive any specific grant from any funding agency in the public commercial or non-profit section.

Author information

Affiliations

Authors

Corresponding author

Correspondence to C. Letizia.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Concistrè, A., Grillo, A., La Torre, G. et al. Ambulatory blood pressure monitoring-derived short-term blood pressure variability in primary hyperparathyroidism. Endocrine 60, 129–137 (2018). https://doi.org/10.1007/s12020-017-1362-x

Download citation

Keywords

  • Short-term blood pressure variability
  • Hypertension
  • Primary hyperparathyroidism
  • ABPM